SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Human Genome Sciences, Inc. (HGSI)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Troll_29 who wrote (72)3/2/1997 10:53:00 PM
From: David Bogdanoff   of 1127
 
The questions you ask regarding patents would really take an expert to answer. IMO the recent intellectual property rights which was entered into by various countries seemed to be directed toward copying of CD's and perhaps other consumer products, and was not a world-wide one step patent system. For patents in the medical areas, the key countries are the US, Japan, and Germany, i.e. the biggest markets. Once these are locked up, it would be difficult to profitably market to the rest of the world expensive and sophisticated medical products. In fact, some medical products for tropical diseases don't get marketed at all because tropical countries are too poor to buy the products, all patent issues aside.

David
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News